Cargando…

Fundamental principles of an effective diabetic retinopathy screening program

BACKGROUND: Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. METHODS: A working group of ophthalmic and diabetes experts was established to develop a consensus on the key prin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanzetta, Paolo, Sarao, Valentina, Scanlon, Peter H., Barratt, Jane, Porta, Massimo, Bandello, Francesco, Loewenstein, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311555/
https://www.ncbi.nlm.nih.gov/pubmed/32222818
http://dx.doi.org/10.1007/s00592-020-01506-8
_version_ 1783549565636444160
author Lanzetta, Paolo
Sarao, Valentina
Scanlon, Peter H.
Barratt, Jane
Porta, Massimo
Bandello, Francesco
Loewenstein, Anat
author_facet Lanzetta, Paolo
Sarao, Valentina
Scanlon, Peter H.
Barratt, Jane
Porta, Massimo
Bandello, Francesco
Loewenstein, Anat
author_sort Lanzetta, Paolo
collection PubMed
description BACKGROUND: Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. METHODS: A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review. RESULTS: The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening. CONCLUSION: Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide.
format Online
Article
Text
id pubmed-7311555
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-73115552020-06-26 Fundamental principles of an effective diabetic retinopathy screening program Lanzetta, Paolo Sarao, Valentina Scanlon, Peter H. Barratt, Jane Porta, Massimo Bandello, Francesco Loewenstein, Anat Acta Diabetol Position Statement BACKGROUND: Diabetic retinopathy (DR) is the leading cause of blindness among working-age adults worldwide. Early detection and treatment are necessary to forestall vision loss from DR. METHODS: A working group of ophthalmic and diabetes experts was established to develop a consensus on the key principles of an effective DR screening program. Recommendations are based on analysis of a structured literature review. RESULTS: The recommendations for implementing an effective DR screening program are: (1) Examination methods must be suitable for the screening region, and DR classification/grading systems must be systematic and uniformly applied. Two-field retinal imaging is sufficient for DR screening and is preferable to seven-field imaging, and referable DR should be well defined and reliably identifiable by qualified screening staff; (2) in many countries/regions, screening can and should take place outside the ophthalmology clinic; (3) screening staff should be accredited and show evidence of ongoing training; (4) screening programs should adhere to relevant national quality assurance standards; (5) studies that use uniform definitions of risk to determine optimum risk-based screening intervals are required; (6) technology infrastructure should be in place to ensure that high-quality images can be stored securely to protect patient information; (7) although screening for diabetic macular edema (DME) in conjunction with DR evaluations may have merit, there is currently insufficient evidence to support implementation of programs solely for DME screening. CONCLUSION: Use of these recommendations may yield more effective DR screening programs that reduce the risk of vision loss worldwide. Springer Milan 2020-03-28 2020 /pmc/articles/PMC7311555/ /pubmed/32222818 http://dx.doi.org/10.1007/s00592-020-01506-8 Text en © The Author(s) 2020, corrected publication 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Position Statement
Lanzetta, Paolo
Sarao, Valentina
Scanlon, Peter H.
Barratt, Jane
Porta, Massimo
Bandello, Francesco
Loewenstein, Anat
Fundamental principles of an effective diabetic retinopathy screening program
title Fundamental principles of an effective diabetic retinopathy screening program
title_full Fundamental principles of an effective diabetic retinopathy screening program
title_fullStr Fundamental principles of an effective diabetic retinopathy screening program
title_full_unstemmed Fundamental principles of an effective diabetic retinopathy screening program
title_short Fundamental principles of an effective diabetic retinopathy screening program
title_sort fundamental principles of an effective diabetic retinopathy screening program
topic Position Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311555/
https://www.ncbi.nlm.nih.gov/pubmed/32222818
http://dx.doi.org/10.1007/s00592-020-01506-8
work_keys_str_mv AT lanzettapaolo fundamentalprinciplesofaneffectivediabeticretinopathyscreeningprogram
AT saraovalentina fundamentalprinciplesofaneffectivediabeticretinopathyscreeningprogram
AT scanlonpeterh fundamentalprinciplesofaneffectivediabeticretinopathyscreeningprogram
AT barrattjane fundamentalprinciplesofaneffectivediabeticretinopathyscreeningprogram
AT portamassimo fundamentalprinciplesofaneffectivediabeticretinopathyscreeningprogram
AT bandellofrancesco fundamentalprinciplesofaneffectivediabeticretinopathyscreeningprogram
AT loewensteinanat fundamentalprinciplesofaneffectivediabeticretinopathyscreeningprogram
AT fundamentalprinciplesofaneffectivediabeticretinopathyscreeningprogram